NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

Which treatment is NOT recommended for PJP in HIV?

Bactrim
Prednisone for 21 days
Valganciclovir
Atovaquone

The correct answer is: Valganciclovir

Valganciclovir is not recommended for the treatment of PJP (Pneumocystis jirovecii pneumonia) in HIV patients. Valganciclovir is an antiviral medication used to treat cytomegalovirus (CMV) infections, not PJP. A. Bactrim (trimethoprim-sulfamethoxazole), D. Atovaquone, and B. Prednisone are all appropriate treatments for PJP in patients with HIV. Bactrim is the preferred first-line treatment for PJP due to its efficacy and lower cost. Atovaquone can be an alternative for patients who are intolerant to Bactrim. Prednisone, a corticosteroid, is often used as an adjunctive therapy to reduce inflammation in patients with moderate to severe PJP.